Inhibitor of cyclin-dependent kinases 4/6, palbociclib showed an inhibitory activity in chordoma cell lines with P16/INK4A loss [60] and more recently in 1 (out of 2) chordoma xenografts with this 9p deletion [61]. The gene discussed is CDKN2A; the disease is chordoma.